Zydus Animal Health And Investments Profile
Key Indicators
- Authorised Capital ₹ 2,300.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1,774.37 Cr
as on 16-11-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 9.03%
(FY 2023)
- Profit -88.60%
(FY 2023)
- Ebitda -11.73%
(FY 2023)
- Net Worth 2.71%
(FY 2023)
- Total Assets 2.41%
(FY 2023)
About Zydus Animal Health And Investments
The Corporate was formerly known as Violio Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2,300.00 Cr and a paid-up capital of Rs 1,774.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zydus Animal Health And Investments Limited India are Hiren Mistry as CFO and Mihir Mehta as Company Secretary. Pramod Lokhande, Chimanlal Patel, Bhavana Doshi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24236GJ2018PLC102269
- Company No.
102269
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 May 2018
- Date of AGM
02 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Zydus Animal Health And Investments?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hiren Mistry | CFO | 04-Oct-2021 | Current |
Mihir Mehta | Company Secretary | 02-Jan-2023 | Current |
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nitinkumar Parekh | Director | 10-May-2018 | Current |
Pramod Lokhande | Whole-Time Director | 04-Oct-2021 | Current |
Chimanlal Patel | Director | 06-Sep-2018 | Current |
Bhavana Doshi | Director | 18-Jun-2020 | Current |
Upenkumar Harshadlal | Nominee Director | 25-Aug-2020 | Current |
Financial Performance and Corporate Structure Insights of Zydus Animal Health And Investments.
Zydus Animal Health And Investments Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.03% increase. The company also saw a substantial fall in profitability, with a 88.6% decrease in profit. The company's net worth moved up by a moderate rise of 2.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Zydus Animal Health And Investments?
In 2023, Zydus Animal Health And Investments had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zydus Healthcare LimitedActive 35 years 4 months
Bhavana Doshi and Nitinkumar Parekh are mutual person
- Dialforhealth Greencross LimitedActive 19 years 5 months
Chimanlal Patel and Nitinkumar Parekh are mutual person
- German Remedies Pharmaceuticals Private LimitedActive 13 years 11 months
Chimanlal Patel and Bhavana Doshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zydus Animal Health And Investments?
Zydus Animal Health And Investments has a workforce of 86 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zydus Animal Health And Investments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zydus Animal Health And Investments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.